Sublicensee Payments. Licensee will pay Licensor ten percent (10%) of all consideration (in the case of in-kind consideration, at fair market value as monetary consideration) received by Licensee from sublicensees, excluding royalties from sublicensees based on Net Sales of any Licensed Products for which Licensor receives payment in accordance with Section 3.1.1
Appears in 5 contracts
Samples: Agreement by And (Regen BioPharma Inc), Agreement by And (Regen BioPharma Inc), Agreement by And (Regen BioPharma Inc)
Sublicensee Payments. Licensee will pay Licensor ten percent (10%) of all consideration (in the case of in-kind consideration, at fair market value as monetary consideration) received by Licensee from sublicensees, excluding royalties from sublicensees based on Net Sales of any Licensed Products for which Licensor receives payment in accordance with Section 3.1.13.3.1
Appears in 3 contracts
Samples: Agreement by And (Regen BioPharma Inc), Agreement by And (Zander Therapeutics, Inc), Agreement by And (Bio-Matrix Scientific Group, Inc.)
